Since establishing our private equity strategy in 1989, we have invested in 360 private equity investments in 41 countries.
|Company||Country||Sector||Description||Deal type||Invest. date|
|Grupo Farmaceutico Somar||Country Mexico||Sector Healthcare||Description Leading pharmaceutical company focused on the development, manufacture and marketing of high-quality generic and branded generic products in Mexico||Deal type Carve-out||Invest. date Oct 2017|
|Fleury S.A.||Country Brazil||Sector Healthcare||Description The largest provider of premium medical diagnostic services in Brazil||Deal type PIPE||Invest. date Oct 2015|
|Grupo Biotoscana||Country Colombia||Sector Healthcare||Description Specialty pharmaceutical company licensing innovative and niche products to market in Latin America||Deal type Buyout||Invest. date Nov 2011|
|Laboratorio LKM||Country Argentina||Sector Healthcare||Description One of the leading specialty pharmaceutical manufacturers in Argentina||Deal type Buyout||Invest. date Oct 2011|
|Fada Pharma||Country Argentina||Sector Healthcare||Description Argentina's leading manufacturer of generic pharmaceuticals for the institutional market||Deal type Buyout||Invest. date Jan 2001|